Clinical utility of proPSA and "Benign" PSA when percent free PSA is less than 15%)

被引：0
|
作者：
Akduman, Bulent [1 ]
机构：
[1] Karaelmas Univ, Tip Fak, Urol Anabilim Dali, Zonguldak, Turkey
来源：
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2005年 / 4卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [31] Clinical evaluation of specific assays for free PSA and total PSA
    Bedeau, N
    Bellanger, L
    Malard, V
    Pons, D
    Seguin, P
    Guillet, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1261 - 1261
  • [32] Accuracy of percent free PSA to predict prostate cancer diagnosis in men with total PSA ranges lower than 2.5 ng/ml
    Haese, A.
    Walz, J.
    Gallina, A.
    Steuber, T.
    Briganti, A.
    Chun, F.
    Graefen, M.
    Montorsi, F.
    Huland, H.
    Karakiewicz, P. I.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 50 - 50
  • [33] Finasteride therapy does not significantly alter the percent free PSA value but decreases free and total serum PSA concentrations by fifty percent
    Giacherio, DA
    Wojno, KJ
    Beduschi, MC
    England, BG
    Oesterling, JE
    Gormley, GJ
    Bach, MA
    Waldstreicher, J
    CLINICAL CHEMISTRY, 1997, 43 : 606 - 606
  • [34] Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels
    Horninger, W
    Reissigl, A
    Klocker, H
    Rogatsch, H
    Fink, K
    Strasser, H
    Bartsch, G
    PROSTATE, 1998, 37 (03): : 133 - 137
  • [35] The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer
    Kochañska-Dziurowicz, AA
    Mielniczuk, MR
    Stojko, A
    Kaletka, J
    BRITISH JOURNAL OF UROLOGY, 1998, 81 (06): : 834 - 838
  • [36] PROPSA IS MORE ACCURATE:PROSPECTIVE PROSTATE CANCER SCREENING STUDY COMPARING [-2]-PROPSA WITH FREE AND TOTAL PSA
    Le, Brian V.
    Griffin, Christopher R.
    Loeb, Stacy
    Kan, Donghui
    Catalona, William J.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 643 - 643
  • [37] The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer
    Woodhams, S
    Greenwell, T
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (06): : 933 - 933
  • [38] The use of the prostate specific antigen (PSA) isoforms, BPH-A and ProPSA, to improve the specificity of PSA tests for cancer and benign prostatic hyperplasia.
    Mikolajczyk, SD
    Weinzierl, CF
    Catalona, WJ
    Cook, BC
    CLINICAL CHEMISTRY, 2005, 51 : A57 - A57
  • [39] Association of free PSA percent, total PSA, age, and gland volume in the detection of prostate cancer
    Mettlin, C
    Chesley, AE
    Murphy, GP
    Bartsch, G
    Toi, A
    Bahnson, R
    Church, P
    PROSTATE, 1999, 39 (03): : 153 - 158
  • [40] Percent free PSA for first time prostate biopsy
    Volgger, H
    Horninger, W
    Niescher, M
    Rogatsch, H
    Klocker, H
    Bartsch, G
    JOURNAL OF UROLOGY, 2002, 167 (04): : 208 - 208
12345